The use of (99m}Tc-Al[2]O[3] for detection of sentinel lymph nodes in breast cancer; AIP Conference Proceedings; Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016

Podrobná bibliografie
Parent link:AIP Conference Proceedings
Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016.— 2016.— [020061, 4 p.]
Korporativní autor: Национальный исследовательский Томский политехнический университет (ТПУ) Физико-технический институт (ФТИ) Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР)
Další autoři: Sinilkin I. G. Ivan Gennadjevich, Chernov V. I. Vladimir Ivanovich, Medvedeva А. А. Anna Aleksndrovna, Zelchan R. V. Roman Vladimirovich, Slonimskaya E., Doroshenko A., Varlamova N. V. Natalya Valeryevna, Skuridin V. S. Viktor Sergeyevich
Shrnutí:Title screen
Purpose: to study the feasibility of using the new radiopharmaceutical based on the technetium-99m-labeled gamma-alumina for identification of sentinel lymph nodes (SLNs) in breast cancer patients. The study included two groups of breast cancer patients who underwent single photon emission computed tomography (SPECT) and intraoperaive gamma probe identification of sentinel lymph nodes (SLNs). To identify SLNs, the day before surgery Group I patients (n=34) were injected with radioactive {99m}Tc-Al[2]O[3], and Group II patients (n=30) received 99mTc-labeled phytate colloid. A total of 37 SLNs were detected in Group I patients. The number of identified SLNs per patient ranged from 1 to 2 (the average number of identified SLNs was 1.08). Axillary lymph nodes were the most common site of SLN localization. 18 hours after {99m}Tc-Al[2]O[3] injection, the percentage of its accumulation in the SLN was 7-11% (of the counts in the injection site) by SPECT and 17-31% by gamma probe detection. In Group II SLNs were detected in 27 patients. 18 hours after injection of the phytate colloid the percentage of its accumulation in the SLN was 1.5-2% out of the counts in the injection site by SPECT and 4-7% by gamma probe. The new radiopharmaceutical based on the {99m}Tc-Al[2]O[3] demonstrates high accumulation in SLNs without redistribution through the entire lymphatic basin. The sensitivity and specificity of {99m}Tc-Al[2]O[3] were 100% for both SPECT and intraoperative gamma probe identification.
Режим доступа: по договору с организацией-держателем ресурса
Jazyk:angličtina
Vydáno: 2016
Témata:
On-line přístup:http://dx.doi.org/10.1063/1.4960280
http://earchive.tpu.ru/handle/11683/35790
Médium: Elektronický zdroj Kapitola
KOHA link:https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=652046

MARC

LEADER 00000nla2a2200000 4500
001 652046
005 20250825113326.0
035 |a (RuTPU)RU\TPU\network\17309 
035 |a RU\TPU\network\17308 
090 |a 652046 
100 |a 20161130a2016 k y0engy50 ba 
101 0 |a eng 
105 |a y z 100zy 
135 |a drcn ---uucaa 
181 0 |a i  
182 0 |a b 
200 1 |a The use of (99m}Tc-Al[2]O[3] for detection of sentinel lymph nodes in breast cancer  |f I. G. Sinilkin [et al.] 
203 |a Text  |c electronic 
300 |a Title screen 
320 |a [References: 12 tit.] 
330 |a Purpose: to study the feasibility of using the new radiopharmaceutical based on the technetium-99m-labeled gamma-alumina for identification of sentinel lymph nodes (SLNs) in breast cancer patients. The study included two groups of breast cancer patients who underwent single photon emission computed tomography (SPECT) and intraoperaive gamma probe identification of sentinel lymph nodes (SLNs). To identify SLNs, the day before surgery Group I patients (n=34) were injected with radioactive {99m}Tc-Al[2]O[3], and Group II patients (n=30) received 99mTc-labeled phytate colloid. A total of 37 SLNs were detected in Group I patients. The number of identified SLNs per patient ranged from 1 to 2 (the average number of identified SLNs was 1.08). Axillary lymph nodes were the most common site of SLN localization. 18 hours after {99m}Tc-Al[2]O[3] injection, the percentage of its accumulation in the SLN was 7-11% (of the counts in the injection site) by SPECT and 17-31% by gamma probe detection. In Group II SLNs were detected in 27 patients. 18 hours after injection of the phytate colloid the percentage of its accumulation in the SLN was 1.5-2% out of the counts in the injection site by SPECT and 4-7% by gamma probe. The new radiopharmaceutical based on the {99m}Tc-Al[2]O[3] demonstrates high accumulation in SLNs without redistribution through the entire lymphatic basin. The sensitivity and specificity of {99m}Tc-Al[2]O[3] were 100% for both SPECT and intraoperative gamma probe identification. 
333 |a Режим доступа: по договору с организацией-держателем ресурса 
461 0 |0 (RuTPU)RU\TPU\network\4816  |t AIP Conference Proceedings 
463 0 |0 (RuTPU)RU\TPU\network\17033  |t Vol. 1760 : Physics of Cancer: Interdisciplinary Problems and Clinical Applications 2016  |o Proceedings of the International conference, 22-25 March 2016, Tomsk, Russia  |f National Research Tomsk Polytechnic University (TPU) ; eds. E. Y. Gutmanas ; O. B. Naimark ; Yu. P. Sharkeev  |v [020061, 4 p.]  |d 2016 
610 1 |a электронный ресурс 
610 1 |a труды учёных ТПУ 
610 1 |a лимфатические узлы 
610 1 |a рак 
610 1 |a радиофармпрепараты 
610 1 |a эмиссионная томография 
610 1 |a компьютерная томография 
610 1 |a технеций-99м 
610 1 |a онкологические заболевания 
701 1 |a Sinilkin  |b I. G.  |c specialist in the field of medical technology  |c laboratory, Tomsk Polytechnic University, candidate of medical science  |f 1972-  |g Ivan Gennadjevich  |3 (RuTPU)RU\TPU\pers\34189 
701 1 |a Chernov  |b V. I.  |c specialist in the field of medical technology  |c lead engineer of Tomsk Polytechnic University, doctor of medical sciences  |f 1962-  |g Vladimir Ivanovich  |3 (RuTPU)RU\TPU\pers\34191 
701 1 |a Medvedeva  |b А. А.  |c specialist in the field of medical technology  |c laboratory assistant of Tomsk Polytechnic University, candidate of medical science  |f 1975-  |g Anna Aleksndrovna  |3 (RuTPU)RU\TPU\pers\37376 
701 1 |a Zelchan  |b R. V.  |c specialist in the field of medical technology  |c laboratory Tomsk Polytechnic University  |f 1984-  |g Roman Vladimirovich  |3 (RuTPU)RU\TPU\pers\34194 
701 1 |a Slonimskaya  |b E. 
701 1 |a Doroshenko  |b A. 
701 1 |a Varlamova  |b N. V.  |c biochemist  |c Researcher of Tomsk Polytechnic University, Candidate of biological sciences  |f 1975-  |g Natalya Valeryevna  |3 (RuTPU)RU\TPU\pers\32659 
701 1 |a Skuridin  |b V. S.  |c Physicist, Specialist in the field of nuclear power engineering  |c Professor of Tomsk Polytechnic University, Doctor of technical sciences  |f 1946-  |g Viktor Sergeyevich  |3 (RuTPU)RU\TPU\pers\32655  |9 16554 
712 0 2 |a Национальный исследовательский Томский политехнический университет (ТПУ)  |b Физико-технический институт (ФТИ)  |b Лаборатория № 31 ядерного реактора (Лаборатория № 31 ЯР)  |3 (RuTPU)RU\TPU\col\20054 
801 2 |a RU  |b 63413507  |c 20170120  |g RCR 
856 4 |u http://dx.doi.org/10.1063/1.4960280 
856 4 |u http://earchive.tpu.ru/handle/11683/35790 
942 |c CF